acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 21 Feb 2024 Announcement from Acarix’s extra general meeting The extra general meeting of Acarix AB (the "Company") was held today on 21 February 2024 and the following resolution was passed by th... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 15 Feb 2024 Acarix strengthens US Advisory Board with three industry leaders New York, New York, February 15, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointmen... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend November 18, 2024 15 Feb 2024 Acarix AB (publ) publishes Year-End Report 2023 Embarking on a new journey with focus on sustainable growthAs the newly appointed CEO of Acarix, I am honored to be on board and share ... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 14 Feb 2024 Invitation to presentation of Acarix´s fourth quarter report Acarix will publish its fourth quarter results on Thursday 15 February 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (C... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 02 Feb 2024 Acarix CADScor System now listed on US Federal Supply Schedule Acarix, a leader in advanced acoustic and algorithm based cardiac diagnostic devices today announces that its CADScor System has been a... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 01 Feb 2024 NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe... Continue reading
acarix Corporate Action, English, IR, Issuance, MAR, mfn-cus-disclaimer, News, Regulatory, Shares November 18, 2024 01 Feb 2024 Acarix carries out a directed share issue of approximately SEK 33.7 million THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 01 Feb 2024 Acarix appoints Aamir Mahmood as new CEO Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 13 Dec 2023 Acarix strengthens US sales leadership team Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces a new US sales structure that aims to further strengthen its... Continue reading
acarix Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory November 18, 2024 30 Nov 2023 Acarix changes Certified Adviser to Carnegie Investment Bank AB (publ) Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces a change of Certified Adviser from Erik Penser Bank AB... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 23 Nov 2023 Southeast Louisiana VA Healthcare System Reorders CADScor Patches Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces an advancement in the utilization of its CADScor® ... Continue reading
acarix Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares November 18, 2024 16 Nov 2023 ACARIX CARRIES OUT A DIRECTED ISSUE TO GUARANTORS FOLLOWING THE COMPLETED RIGHTS ISSUE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG ... Continue reading